CVS HEALTH CORPORATION (CVS) FY2025 Q1 P&L / Income Statement
2025-01-01 to 2025-03-31
Revenue by Product and Service
2025-01-01 to 2025-03-31
Swipe to see the full flow
Chart details
CVS HEALTH CORPORATION (CVS) FY2025 Q1 P&L / Income Statement
Income statement for 2025-01-01 through 2025-03-31. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Total revenues
- 94,588,000,000 US dollars
- Total operating costs
- 91,214,000,000 US dollars
- Operating income
- 3,374,000,000 US dollars
- Other income (expense), net (calculated)
- negative 757,000,000 US dollars
- Income before income tax provision
- 2,617,000,000 US dollars
- Income tax provision
- 835,000,000 US dollars
- Net income
- 1,782,000,000 US dollars
- Products
- 57,669,000,000 US dollars
- Services
- 3,579,000,000 US dollars
- Premiums
- 32,820,000,000 US dollars
- Net investment income
- 520,000,000 US dollars
- Cost of products sold
- 51,057,000,000 US dollars
- Health care costs
- 29,135,000,000 US dollars
- Operating expenses
- 11,022,000,000 US dollars
Chart connections
- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CVS HEALTH CORPORATION: $1.78 B; to noncontrolling interests: $3.00 M.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Operating margin
3.6%
Operating profit / revenue
Cash conversion
255.7%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
